Sunday, June 21, 2009

Lambton County Released Infectious Disease Report

Lambton County Released Infectious Disease Report

The County of Lambton Community Health Services Department has released a Health Status Report on Infectious Diseases. This report examines the incidence of reportable infectious diseases in Lambton County and compares local rates to those in Ontario and Canada.

The County of Lambton Community Health Services Department (CHSD) has released a Health Status Report on Infectious Diseases.

This report examines the incidence of reportable infectious diseases in Lambton County and compares local rates to those in Ontario and Canada.

Data from local, provincial and national surveillance systems were analyzed and reported for the years 1996 to 2007. The report revealed that Lambton rates are similar to or lower than Ontario and Canadian rates for most reportable infectious diseases.

Source: 
Lambton County Community Health Services Department

Friday, June 19, 2009

New Treatments Should Be Introduced Gradually To Avoid Later Problems, Says Expert

Concerns over whether the tests a treatment undergoes before release onto the market are enough to ensure its long-term safety are raised in an editorial published by BMJ Clinical Evidence today. Dr Vijay Sharma suggests that treatments should be introduced gradually so that evidence can be built up and the treatment can find its proper niche. To illustrate this, he discusses the recent debate on the long-term safety of drug-eluting stents. Complete news at...

Wednesday, June 17, 2009

Bayer Completes Phase II Study On BAY 94-9172 In Alzheimer's Disease Imaging

Bayer Schering Pharma AG, Germany, has completed its first global Phase II study analyzing the sensitivity and specificity of BAY 94-9172 (AV1/ZK) using positron emission tomography (PET) in patients with probable Alzheimer's disease compared to healthy volunteers. BAY 94-9172 binds to the beta amyloid protein in the brain, a pathological hallmark of Alzheimer's disease. More at...